W. Poewe Et Al. , "Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: An active treatment extension study," MOVEMENT DISORDERS , vol.21, no.4, pp.456-461, 2006
Poewe, W. Et Al. 2006. Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: An active treatment extension study. MOVEMENT DISORDERS , vol.21, no.4 , 456-461.
Poewe, W., Wolters, E., Emre, M., Onofrj, M., Hsu, C., Tekin, S., ... Lane, R.(2006). Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: An active treatment extension study. MOVEMENT DISORDERS , vol.21, no.4, 456-461.
Poewe, W Et Al. "Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: An active treatment extension study," MOVEMENT DISORDERS , vol.21, no.4, 456-461, 2006
Poewe, W Et Al. "Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: An active treatment extension study." MOVEMENT DISORDERS , vol.21, no.4, pp.456-461, 2006
Poewe, W. Et Al. (2006) . "Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: An active treatment extension study." MOVEMENT DISORDERS , vol.21, no.4, pp.456-461.
@article{article, author={W Poewe Et Al. }, title={Long-term benefits of rivastigmine in dementia associated with Parkinson's disease: An active treatment extension study}, journal={MOVEMENT DISORDERS}, year=2006, pages={456-461} }